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Abstract Focalsegmentalglomerulosclerosis(FSGS)
involves considerable histological heterogeneity in
terms of location and quality of the glomerular
segmental lesions. The present study investigated the
heterogeneity of segmental lesions in each variant of
FSGS, determined by the Columbia classiﬁcation, and
itsclinicalrelevance.Allglomerularsegmentallesions
of 80 cases of primary FSGS were evaluated histolog-
ically based on location [tip (TIP), perihilar (PH), or
nototherwisespeciﬁed(NOS)],andquality(cellularor
ﬁbrous). Among the 1,299 glomeruli of the 80 biopsy
specimens, 210 glomeruli (16.2%) had segmental
lesions, comprising 57 (27%) cellular TIP, 4 (2%)
ﬁbrous TIP, 42 (20%) cellular NOS, 86 (41%) ﬁbrous
NOS, and 21 (10%) ﬁbrous PH lesions. Each case was
also classiﬁed into one of the ﬁve histological variants
of the Columbia classiﬁcation: collapsing (COL), TIP,
cellular (CEL), PH, or NOS. Overlap of segmental
lesions in different location categories was seen in the
COL, TIP, and PH variants, and heterogeneity of
quality was apparent in the COL and CEL variants.
HistologicalﬁndingsoftheCELvariant(endocapillary
hypercellularity) were observed in nine of the 13 COL
variants. Both location and quality correlated with
disease duration, degree of proteinuria, and histolog-
ical severity of global glomerular sclerosis and tubulo-
interstitial lesions. These results demonstrated the
histological heterogeneity of glomerular segmental
lesions in all variants of the Columbia classiﬁcation,
except NOS. However, the ﬁdelity of location and
dominance of histological features were generally
conserved in the TIP and PH variants. The COL and
CEL variants warrant further investigation because of
their overlapping histological ﬁndings and apparent
histologicalheterogeneityintheglomerularsegmental
lesions.
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Focal segmental glomerulosclerosis (FSGS) is a mor-
phologically deﬁned renal disease characterized by
diverse clinical manifestations. Many patients with
FSGS display a progression to advanced glomerular
sclerosis and subsequent end-stage renal disease
(ESRD) [1]. The etiology of FSGS is typically
unknown but recent investigations have revealed that
many distinct factors, includingageneticabnormality,
are involved in the pathogenesis of secondary FSGS,
affecting the disturbance of podocytes and slit dia-
phragm morphology and function [2].
Recently, a working formulation for the morpho-
logical classiﬁcation of primary FSGS, the ‘‘Colum-
bia classiﬁcation,’’ was proposed by D’Agati et al.
[3]. It includes ﬁve histological variants: collapsing
(COL), tip (TIP), cellular (CEL), perihilar (PH), and
not otherwise speciﬁed (NOS). Several studies have
reported signiﬁcant differences in the clinical features
and outcomes among patients with different histo-
logical variants of FSGS, based on the Columbia
classiﬁcation [4–8]. The utility of the Columbia
classiﬁcation in renal transplant allografts has been
studied recently [9, 10]. In one study, the majority of
recurrent FSGS presented the same variant as the
original FSGS in the native kidney [9], whereas
another study found that the variant of FSGS in the
native kidneys was not predictive of either recurrence
or the type of FSGS observed in the allograft [10].
Thus, it remains unclear whether different Columbia
variants represent different pathophysiological enti-
ties of FSGS or different stages of the same
pathophysiological entity.
A detailed histological observation of glomerular
segmental lesions in FSGS indicated that patients
with severe clinical manifestation often presented
similar histological features, such as proliferation of
intrinsic glomerular cells comprising epithelial and
endothelial cells. The accumulation of inﬁltrating
leukocytes and foam cells within the glomerular
capillary was also observed in the segmental lesions.
Conversely, patients with advanced glomerular scle-
rosis and impaired renal function generally exhibited
a consolidation of glomerular tufts with an increase
of extracellular matrix, resulting in segmental glo-
merular sclerosis [11]. These histological qualities
of the segmental lesions are reﬂected by a mix-
ture of activity and chronicity of the glomerular
inﬂammatory process. The histological activity and
chronicity signiﬁcantly correlate with the clinical
manifestations and outcomes in various glomerular
diseases. A recently revised classiﬁcation for lupus
nephritis [12] and similar attempts for IgA nephrop-
athy [13–17] that consider the histological activity
and chronicity of glomerular lesions appear to be
beneﬁcial for the clinical management of kidney
diseases.
In the Columbia classiﬁcation, the variants COL,
TIP, and CEL predominantly display different
aspects of histological activity, such as glomerular
epithelial cell proliferation and intracapillary hyper-
cellularity, whereas the variants PH and NOS usually
show histological chronicity, such as consolidation of
glomerular tufts. However, it is uncertain whether
variants contain a uniform or mixed histological
quality (activity/chronicity) of segmental lesions, and
whether the histological quality has implications for
clinical manifestation. Furthermore, it is not known
whether a mutual relationship exists between the
location and quality of glomerular segmental lesions.
In the present study, we evaluated histologically
the glomerular segmental lesions from 80 cases of
primary FSGS with respect to location and histolog-
ical quality. Each case was further classiﬁed into one
of the ﬁve histological variants of the Columbia
FSGS classiﬁcation, and the histological heterogene-
ity of each variant was analyzed. Our ﬁndings
indicate the presence of histological heterogeneity
in each variant of the Columbia classiﬁcation and the
importance of quality and location for assessing
disease activity in patients with FSGS.
Materials and methods
Eighty biopsy-proven cases of primary FSGS seen at
the Department of Medicine, Kidney Center, Tokyo
Women’s Medical University between 1982 and 2007
were enrolled in the study. Five glomeruli per biopsy
specimen was the minimum requirement for enroll-
ment in this study. The average number of glomeruli
per one biopsy specimen was 16.2 ± 11.7. FSGS was
diagnosed based on the presence of glomerular
segmental lesions in at least one glomerulus in 40
consecutive sections. A segmental lesion was deﬁned
as a consolidation of the glomerular tuft due to
luminal collapse and a subsequent increase of cellular
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123components and extracellular matrix. Hyalinosis was
occasionallyassociatedwiththe segmentallesions.The
cellular components consisted of intrinsic glomerular
cells, such as glomerular epithelial, endothelial and
mesangial cells, and inﬁltrating leukocytes and foam
cells (macrophages).
The diagnostic algorithm of FSGS is described in
Fig. 1. Patients diagnosed with other primary glomer-
ulardiseases,collagendiseases,systemicvasculitis,or
diabetes were excluded. No patient was diagnosed
with malignant hypertension, morbid obesity, viral
infection, or drug-induced nephropathy. The subjects
in this study were all adults (range, 18–77 years-old,
average age: 39.4 ± 1.7). There was no familial
clusteringofFSGSinthesepatients.Thus,thesubjects
were diagnosed mostly with primary (idiopathic)
FSGS, but the possibility of secondary FSGS, medi-
ated by adaptive glomerular changes to hypertension
or non-morbid obesity, could not be completely
excluded.
All subjects agreed to participate in this study and
provided written informed consent.
Clinical data of the 80 patients with primary
FSGS
Renal function was evaluated based on the serum
creatinine levels (sCr, mg/dl) at the time of biopsy
and the end of follow-up. The level of proteinuria
(g/day) was also evaluated at biopsy and ﬁnal obser-
vation.Theinterval(months)betweenthediscoveryof
proteinuria and the kidney biopsy was regarded as the
disease duration. Nephrotic-range proteinuria was
deﬁned as urinary protein excretion (U-p): C 3.0 g/day.
Hypertension was deﬁned as systolic blood pressure
of C 150 mmHg and diastolic blood pressure of C
90 mmHg. Malignant hypertension was deﬁned as
diastolic blood pressure of C 130 mmHg accompa-
nied by papilledema or retinal hemorrhage. Obesity
was deﬁned as a body mass index (BMI) C 30 kg/m
2,
andmorbidobesitywasdeﬁnedasaBMI C 40 kg/m
2.
Remission of FSGS was deﬁned as a reduction of
proteinuria to less than 0.5 g/day. End-stage renal
disease (ESRD) was deﬁned as a clinical state requir-
ing regular renal replacement therapy.
Variant classiﬁcation and histological evaluation
of glomerular segmental lesions in FSGS
Three pathologists (ST, KH, and MN) jointly
reviewed the glomerular segmental lesions using a
multi-head optical microscope to reach a consensus
diagnosis for location and quality of lesions, and the
variant of the Columbia classiﬁcation. Glomerular
segmental lesions were evaluated by their location
and quality, according to the following procedures:
The location of segmental lesion in each glomerulus
was ﬁrst categorized into three types: tip (TIP),
perihilar (PH), or not otherwise speciﬁed (NOS). The
TIP area was deﬁned as the outer 25% of the
glomerular tuft around the tubular pole, the PH area
was deﬁned as the proximal 25% of the glomerular
tuft around the vascular pole, and any location that
was not in the TIP or PH areas was considered to be
NOS. Next, the quality of each segmental lesion was
Fig. 1 Screening program for diagnosis and etiologies of
FSGS.FSGSwasdiagnosedbasedonthepresenceofglomerular
segmental lesions in at least one glomerulus. Patients diagnosed
withotherprimaryglomerulardiseasesorsystemicdisease,such
as collagen diseases, vasculitis, or diabetes, were excluded. No
patient was identiﬁed with a cause for secondary FSGS. Thus,
the subjects of this study were diagnosed mostly with primary
(idiopathic) FSGS
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123subtyped as cellular or ﬁbrous, based on its predom-
inant histological features. The cellular subtype was
characterized by a proliferation of glomerular epi-
thelial cells and/or intracapillary occlusion with
hypercellularity, including foam cells and inﬁltrated
leukocytes. The ﬁbrous subtype was characterized by
a consolidation of the glomerular tuft with increased
extracellular ﬁbrous matrix (sclerosis). Hyalinosis
was observed in both the cellular and ﬁbrous
subtypes. Finally, each case was classiﬁed as one of
the ﬁve histological variants of the Columbia classi-
ﬁcation: collapsing (COL), tip (TIP), cellular (CEL),
perihilar (PH), or NOS [3].
Determination of dominant location and quality
of segmental lesions
The dominant location and quality of the segmental
lesions in all cases was determined using the
following methods. The most frequent location
pattern among all segmental lesions in a given case
was assigned as the dominant location category of
that case. When the number of lesions in each
location category were the same, the priority order
was deﬁned as TIP[PH[NOS. The quality of the
segmental lesions in each case was determined to be
cellular when all lesions were cellular, ﬁbrous when
all lesions were ﬁbrous, and ﬁbrocellular when
cellular and ﬁbrous subtypes co-existed in the same
biopsy specimen. Clinical and histological features
were compared according to the dominant location
category or quality subtype, respectively.
Grading of other histological lesions
The number of glomeruli exhibiting global sclerosis
(GS) or segmental sclerosis (SS) was calculated as a
percentage of the total number of glomeruli, GS or SS,
respectively, in each specimen. Interstitial ﬁbrosis and
tubular atrophy (IF/TA) were graded semi-quantita-
tively, based on the affected cortical area, as a percent-
ageofthetotalcorticalarea,where0 = absentor\5%,
1 ?=6–25%, 2 ?=26–50%, and 3 ?=[50%.
Statistical analysis
Continuous variables are presented as means ± stan-
dard error (SEM). Statistical analysis between two
groups was performed using Student’s t-test or the
Mann–Whitney U-test, and analysis among multiple
groups was performed using one-way or two-way
ANOVA. Multiple comparisons (post hoc) using
Scheffe’s test were performed to compare continuous
variables between two groups. The ratio of patients
with ESRD was compared by Ryan’s test. Analyses
were performed using the SAS software (ver. 9.1.3;
SAS Institute, Inc., Cary, NC, USA), and Ryan’s test
was performed using the ‘R’ statistical analysis
package. Statistical signiﬁcance was accepted for
P-values\0.05.
Results
Histological variants according to the Columbia
classiﬁcation
The 80 cases of FSGS were classiﬁed according to
the Columbia classiﬁcation as follows: COL, 13 cases
(16.2%); TIP, 24 cases (30.0%); CEL, 11 cases
(13.8%); PH, 13 cases (16.2%); and NOS, 19 cases
(23.8%; Fig. 2). The correspondence between the
variant obtained by Columbia classiﬁcation and the
category determined by the dominant location and
quality factor is shown in Table 1. The 13 cases of
the COL variant included cases categorized as TIP
cellular (2 cases), NOS cellular (4), NOS ﬁbrocellular
(5), and PH ﬁbrocellular (2). Most of the 24 TIP
variant cases were categorized as TIP cellular (18
cases), with three cases of TIP ﬁbrocellular, one of
COL
16%
TIP
30%
CEL
14%
PH
16%
NOS
24%
FSGS (n=80)
n=13
n=19
n=24 n=13
n=11
Fig. 2 Histological variants according to the Columbia classi-
ﬁcation. The 80 cases of FSGS were classiﬁed according to the
Columbiaclassiﬁcationasfollows:COL,13cases(16.2%),TIP,
24cases(30.0%),CEL,11cases(13.8%),PH,13cases(16.2%),
and NOS, 19 cases (23.8%)
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123NOS ﬁbrocellular, and two of NOS ﬁbrous. Among
the 11 cases of the CEL variant, there were ﬁve NOS
cellular cases and six NOS ﬁbrocellular cases. All 13
cases of the PH variant were categorized as PH
ﬁbrous. Nearly all of the 19 cases of the NOS variant
were categorized as NOS ﬁbrous (18), with one NOS
ﬁbrocellular case.
Baseline clinical ﬁndings and outcomes
A comparison of the baseline clinical ﬁndings among
the FSGS variants is presented in Table 2. The
histological variants showed signiﬁcant differences
in the mean interval between discovery of proteinuria
and biopsy and in the mean levels of sCr, serum
albumin (sAlb), and urinary protein excretion at the
timeofthekidneybiopsy(Table 2).Themeaninterval
between discovery of proteinuria and biopsy was
shortest for the TIP variant (7.8 ± 2.3 months), fol-
lowed by the CEL (18.7 ± 5.4 months) and COL
variants (41.6 ± 16.2 months), with considerably
longer times for the NOS (89.0 ± 5.4 months) and
PH variants (136.0 ± 27.7 months). The sCr level at
biopsy was highest in the COL variant (2.04 ±
0.54 mg/dl), followed by the CEL variant (1.58 ±
0.18 mg/dl).ThesAlblevelatbiopsywaslowestinthe
CEL variant (2.84 ± 0.32 g/dl) and TIP variant
(2.88 ± 0.20 g/dl), followed by the COL variant
(3.07 ± 0.31 g/dl). Proteinuria at biopsy was high in
the CEL (8.9 ± 2.3 g/day), TIP (8.8 ± 2.3 g/day),
and COL variants (7.1 ± 2.6 g/day), and was rela-
tively low in the NOS (1.7 ± 0.5 g/day) and PH
variants (2.1 ± 0.5 g/day). The prevalence of nephro-
tic syndrome was highest in TIP (72.7%) and CEL
(72.7%) variants, followed by the COL variant
(46.2%), and much lower in PH (16.7%) and NOS
(11.1%) variants.
The therapeutic modalities and outcomes among
the variants are shown in Table 3. Steroids were
usually administered, either alone or combined with
immunosuppressive agents, in the COL (72.8%), TIP
(86.3%), and CEL (70%) variants. Angiotensin
converting enzyme inhibitors (ACEI) or angiotensin
II receptor blockers (ARB) were frequently admin-
istered to all variants (41/75, 52.4%), and ACEI/ARB
administration without steroids was preferred in the
PH variant (84.6%). LDL apheresis was performed in
two of the CEL cases and in one of the COL and TIP
cases, to treat severe dyslipidemia. Sixty-six cases
were followed and their outcomes were evaluated.
Persistent proteinuria was evident in all variants;
however, at ﬁnal observation, the proteinuria levels
were low and showed no difference among the
variants. Additionally, the sCr level at the ﬁnal
evaluation did not differ among the variants, probably
due to the small number of cases and the relatively
short period of observation (55.9 ± 8.8 months). The
rate of remission was higher in the TIP (82.2%)
variant than in the other variants [CEL (60%), NOS
(47.1%), COL (44.4%), and PH (30%)]. Twelve of
the 66 cases (18.2%) progressed to ESRD and
began HD. These included two of the 19 cases with
the TIP variant (10.5%), and relatively higher per-
centages of those with COL (3/10, 30%) and CEL
variants (3/9, 33.3%), with no signiﬁcant difference
betweenthelasttwo.Nopatientwith PHprogressedto
ESRD.
Histological ﬁndings
Histological ﬁndings in a total of 1,299 glomeruli
were assessed in the biopsy specimens of the 80
patients (Table 4). Among these, 207 glomeruli
(15.9%) were globally sclerotic, and 210 (16.2%)
were segmentally sclerotic, with an average of
Table 1 Correspondence of the variant by Columbia classiﬁ-
cation to the category determined by dominant location/quality
factor
Columbia classiﬁcation
(number of cases)
Dominant location/quality
factor (number of cases)
COL (13) TIP-C (2)
NOS-C (4)
NOS-F/C (5)
PH-F/C (2)
TIP (24) TIP-C (18)
TIP-F/C (3)
NOS-F/C (1)
NOS-F (2)
CEL (11) NOS-C (5)
NOS-F/C (6)
PH (13) PH-F (13)
NOS (19) NOS-F/C (1)
NOS-F (18)
COL collapsing variant, TIP tip variant, CEL cellular variant,
PH perihilar variant, NOS not otherwise speciﬁed variant,
C cellular, F/C ﬁbrous/cellular, and F ﬁbrous
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1232.63 ± 0.20 segmentally sclerotic glomeruli per
biopsy specimen. The percentage of global glomer-
ular sclerosis (%GS) differed signiﬁcantly among
variants (P = 0.036), with higher values for the NOS
(23.6 ± 5.1%) and COL variants (21.1 ± 5.9%),
followed by the CEL (17.5 ± 4.1%) and PH variants
(16.8 ± 2.9%), and then the TIP variant (8.0 ±
2.3%). However, the percentage of segmental glo-
merular sclerosis (%SS) was not signiﬁcantly differ-
ent among the variants. The total percentage of GS
plus SS (%GS ? SS) differed signiﬁcantly among the
variants (P = 0.0105), with higher values for the
COL (41.9 ± 6.1%), CEL (42.2 ± 5.5%), and NOS
variants (42.2 ± 5.2%), followed by the PH variants
(32.8 ± 4.0%) and the TIP variants (25.1 ± 2.7%).
The IF/TA score also differed signiﬁcantly among the
variants (P = 0.0106); the CEL variant had the
highest score (2.10 ± 0.27), followed by the NOS
(1.79 ± 0.18), COL (1.62 ± 0.26), and PH variants
(1.54 ± 0.18), with the TIP variant having the lowest
score (1.04 ± 0.16).
Heterogeneity of segmental lesions in each
histological variant
All glomeruli with segmental sclerosis were inde-
pendently evaluated in terms of location and quality
of the segmental lesions. The histological character-
istics of segmental lesions in terms of location and
quality factor are presented in Fig. 3. Segmental
lesions were localized as TIP (Fig. 3a, b), PH
(Fig. 3f) or NOS (Fig. 3c, d, e). Cellular segmental
lesions were characterized by a proliferation of
glomerular epithelial cells (Fig. 3a, c, d) and/or
intracapillary occlusion with hypercellularity, includ-
ing foam cells and inﬁltrated leukocytes (Fig. 3a, d).
Fibrous lesions showed consolidation (sclerosis) of
the glomerular tuft with increased extracellular
matrix (Fig. 3b, e, f). Hyalinosis was observed in
both cellular and ﬁbrous lesions (Fig. 3f). The 210
glomerular segmental lesions consisted of 57 (27%)
cellular TIP, four (2%) ﬁbrous TIP, 42 (20%) cellular
NOS, 86 (41%) ﬁbrous NOS, and 21 (10%) ﬁbrous
PH lesions (Fig. 4). The majority of segmental
lesions in the TIP area were cellular (57/62,
93.4%), and only a small percentage were ﬁbrous
(5/62, 8.1%). In contrast, all 21 segmental lesions in
the PH area were ﬁbrous. The segmental lesions in
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123the NOS area were either cellular (42/127, 33.1%) or
ﬁbrous (86/127, 66.9%).
The location heterogeneity of segmental lesions in
each histological variant is shown in Fig. 5. The
different degrees of heterogeneity were probably
associated with the diagnostic hierarchy of the
Columbia classiﬁcation, which validated the diag-
nostic priority in the order COL, TIP, CEL, PH, and
NOS. In the COL variant, segmental lesions were
located in the TIP (12/51, 23.5%), NOS (36/51,
70.6%), and PH areas (3/51, 5.9%). In the TIP
variant, segmental lesions were located in the TIP
(49/75, 65.3%) and NOS areas (26/75, 34.7%), but
not in the PH area. Half of the patients with the TIP
variant (12/24, 50%) had segmental lesions located in
the NOS area, but the dominant location of the
segmental lesions was in the TIP area in 21/24
(87.5%) cases (Table 1). All of the segmental lesions
in CEL variants were located in the NOS area (28/28,
100%). The majority of the segmental lesions in PH
variants were located in the PH area (18/21, 85.7%),
with only three (14.3%) in the NOS area. Among the
13 patients with the PH variant, three patients
(23.1%) had segmental lesions in the NOS area, but
the PH area in all PH variants was the dominant
location of the segmental lesions (Table 1). All NOS
variant segmental lesions were located in the NOS
area (35/35, 100%).
The quality heterogeneity of segmental lesions in
each histological variant is shown in Fig. 6. Of the 51
COL variant segmental lesions, 32 (62.7%) were
cellular, and 19 (37.3%) were ﬁbrous. The cellular
subtype was also predominant for the TIP (51/75,
68%) and CEL variants (16/28, 57.1%). In contrast,
all segmental lesions of the NOS and PH variants
were ﬁbrous.
Overlap of histological ﬁndings in COL and CEL
variants
Overlap of CEL lesions in the COL variants
occasionally made it difﬁcult to determine the
variant. Because the Columbia classiﬁcation deﬁnes
the COL variant as ‘‘at least one glomerulus with
segmental or global collapse with overlying podocyte
hypertrophy and hyperplasia’’ [3], CEL lesions,
deﬁned as endocapillary hypercellularity occluding
lumina with or without foam cells and karyorrhexis,
can occasionally be admitted in the COL variant
(Fig. 7). The coexistence of CEL lesions in the COL
variants were observed in 9 of 13 COL cases
(Supplemental Table 1). Although proteinuria tended
to be higher in the COL variants with CEL lesions, no
signiﬁcant difference was demonstrated.
Dominant location/quality factors of segmental
lesions correlation with clinical ﬁndings
Figure 8comparesclinicalparametersaccordingtothe
dominantlocationandqualityfactorofeachcase.With
respect to predominant lesion location, the mean
interval between symptom onset and biopsy was
signiﬁcantly shortest for patients with lesions predom-
inantly in the TIP location (4.8 ± 1.1 months), fol-
lowedbytheNOSlocation(52.5 ± 10.1 months),and
the interval was longest for the PH location
(137.9 ± 24.1 months). With respect to predominant
quality factor, the mean interval was shortest for
patients with lesions of the cellular subtype (5.7 ±
1.0 months), longer for the ﬁbrocellular subtype
(40.8 ± 12.1 months), and longest for the ﬁbrous
subtype (105.0 ± 15.4 months; Fig. 8a). Protein-
uria at biopsy was highest for patients with the
Table 4 Comparison of histological ﬁndings of 80 FSGS patients categorized by Columbia classiﬁcation
All COL TIP CEL PH NOS ANOVA
P value
Multiple
comparison
(Sheffe) P\0.05
% GS 16.6 ± 1.9 21.1 ± 5.9 8.0 ± 2.3 17.5 ± 4.1 16.8 ± 2.9 23.6 ± 5.1 0.0361 ns
% SS 18.9 ± 1.3 20.8 ± 3.7 17.1 ± 2.0 24.7 ± 5.2 16.0 ± 13.0 18.6 ± 2.3 ns
%G S? SS 35.3 ± 2.1 41.9 ± 6.1 25.1 ± 2.7 42.2 ± 5.5 32.8 ± 4.0 42.2 ± 5.2 0.0105 ns
IF/TA score (0–3) 1.53 ± 0.10 1.62 ± 0.26 1.04 ± 0.16 2.10 ± 0.27 1.54 ± 0.18 1.79 ± 0.18 0.0106 CEL vs. TIP
Gl glomerular, GS global sclerosis, SS segmental sclerosis, IF/TA interstitial ﬁbrosis and tubular atrophy
Quantitative variables are mean ± standard error of mean
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123Fig. 3 Typical glomerular ﬁndings of segmental lesions regard-
ing location and histological features. a TIP-located lesion with
cellular histology (TIP-cellular). There is segmental accumula-
tion of endocapillary foam cells involving the peripheral
glomerular segment at the tubular pole. Podocytes overlying
the segmental lesion are hypertrophic and hyperplastic. The
histological variant of this glomerulus corresponds to TIP in
the Columbia classiﬁcation (silver methenamine stain, 9100).
b TIP-located lesion with ﬁbrous histology (TIP-ﬁbrous). The
glomerular tufts are collapsed with segmental accumulation of
extracellular matrix involving the peripheral glomerular segment
at the tubular pole. Podocytes overlying the segmental lesion are
slightly proliferative. The histological variant of this glomerulus
also corresponds to TIP in the Columbia classiﬁcation. As a TIP-
cellular lesion co-existed in the same specimen, the histological
category of this case was deemed TIP-ﬁbrocellular (F/C) (PAS
stain, 9100). c Extensive segmental lesion in the NOS area with
cellular histology (NOS-cellular). The glomerulus shows exten-
sive collapse and obliteration of the glomerular tufts, accompa-
nying prominent hypertrophy and hyperplasia of the overlying
glomerular epithelial cells. This case is categorized as NOS-
cellular and classiﬁed as a COL variant in the Columbia
classiﬁcation (silver methenamine stain, 9100). d Segmental
lesionintheNOSareawithactiveendocapillarycellularhistology
(NOS-cellular). Endocapillary accumulation of foam cells and
leukocytes occluding the glomerular capillary lumina is regarded
as an active histological feature of glomerular segmental lesions.
This case is categorized as NOS-cellular and classiﬁed as a CEL
variant in the Columbia classiﬁcation. In addition to endocapil-
lary proliferation, collapsing glomerular tufts may also be
observed in some areas of the segmental lesion, making it
difﬁcult to differentiate between the COL and CEL variants
(silver methenamine stain, 9100). e NOS-located lesion with a
predominantly ﬁbrous appearance (NOS-ﬁbrous). Extensive
segmental sclerosis is observed involving the NOS area, but at
neither the vascular nor tubular pole. No cellular proliferation is
seen in the segmental lesion. The case is categorized as NOS-
ﬁbrousandclassiﬁedasNOSintheColumbiaclassiﬁcation(PAS
stain,9100).fPH-locatedlesionshowingsegmentalocclusionof
the glomerular capillaries by ﬁbrous matrix accumulation and
hyalinosis around the glomerular hilum (PH-ﬁbrous). Neither
epithelial hyperplasia nor endothelial proliferation is seen in this
glomerulus. This case is categorized as PH-ﬁbrous and classiﬁed
asthePHvariantintheColumbiaclassiﬁcation(PASstain,9100)
Int Urol Nephrol (2012) 44:183–196 191
123predominantlyTIPlesionlocation(10.4 ± 2.2 g/day),
followed by the NOS location (4.6 ± 1.0 g/day), and
the PH location (2.1 ± 0.4 g/day). Proteinuria was
highest in the cellular subtype (11.8 ± 1.9 g/day),
followed by the ﬁbrocellular (3.4 ± 1.0 g/day), and
ﬁbrous subtypes (1.9 ± 0.3 g/day; Fig. 8b). The sCr
level at ﬁnal observation was highest for the
TIP (Cell)
27%
TIP (Fib)
2%
NOS (Cell)
20%
NOS (Fib)
41%
PH (Fib)
10%
Segmental lesions (n=210)
Fig. 4 Composition of location and quality factors in all
segmental lesions (n = 210). The 210 glomerular segmental
lesions consisted of 57 (27%) cellular TIP, four (2%) ﬁbrous
TIP, 42 (20%) cellular NOS, 86 (41%) ﬁbrous NOS, and 21
(10%) ﬁbrous PH lesions. The majority of segmental lesions in
the TIP area were cellular, whereas all 21 segmental lesions in
the PH area were ﬁbrous. The segmental lesions in the NOS
area were mixed cellular (33.1%) and ﬁbrous (66.9%)
0  10 20 30 40 50 60 70 80 
NOS variant
PH variant
CEL variant
TIP variant
COL variant
Number of segmental lesion in each location; TIP, NOS, or PH  area in each 
FSGS variant.
NOS variant PH variant CEL variant TIP variant COL variant
TIP area 0 0 0  49  12 
NOS area 35 3 28  26  36 
PH area 0 18 0  0  3 
Location heterogeneity of segmental lesions in each  FSGS variant
Fig. 5 Location heterogeneity of segmental lesions in each
histological variant. Heterogeneity in terms of location was
present of the segmental lesions. In the COL variant, segmental
lesions were located in the TIP (12/51, 23.5%), NOS (36/51,
70.6%), and PH areas (3/51, 5.9%). In the TIP variant,
segmental lesions were located in the TIP (49/75, 65.3%) and
NOS areas (26/75, 34.7%), but not in the PH area. All
segmental lesions in the CEL variant were located in the NOS
area (28/28, 100%). Most of the segmental lesions in the PH
variant were located in the PH area (18/21, 85.7%), with three
located in the NOS area (3/21, 14.3%). All segmental lesions in
the NOS variant were located in the NOS area (35/35, 100%).
Gray bars, TIP area; dashed bars, NOS area; dotted bars,P H
area
Fig. 7 Overlap of COL and CEL lesion histological ﬁndings.
The glomerulus showed the coexistence of segmental tuft
collapse (arrow head) and endocapillary hypercellularity with
intracapillary foam cells (arrow). Overlap between the CEL
lesion in the COL variant sometimes made it difﬁcult to
determine the variant. The CEL lesion was present in nine of
13 cases with COL variants in this study (silver methenamine
stain, 9200)
0  10 20 30 40 50 60 70 80 
NOS variant
PH variant
CEL variant
TIP variant
COL variant
Number of segmental lesions with cellular or fibrousg subtype in  each 
FSGS variant.
NOS variant PH variant CEL variant TIP variant COL variant
Cellular 0  0  16 51 32 
Fibrous 35 21 12 24 19 
Quality heterogeneity of segmental lesionsin each FSGS variant
Fig. 6 Quality heterogeneity of segmental lesions in each
histological variant. The quality composition, cellular (white
bars) and ﬁbrous (black bars) segmental lesions, in each
variant is shown. Among the 210 segmental lesions, 99/210
(47.1%) were cellular and 111/210 (52.9%) were ﬁbrous. In the
COL variant, 32/51 (62.7%) were cellular and 19/51 (37.3%)
were ﬁbrous. The cellular subtype was also predominant in the
TIP (51/75, 68%) and CEL variants (16/28, 57.1%). In
contrast, all segmental lesions were ﬁbrous in the NOS and
PH variants. Gray bars, cellular; black bars, ﬁbrous
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123predominantly NOS location (4.0 ± 0.8 mg/dl) and
was lower for the TIP location (1.4 ± 0.4 mg/dl) and
PH location (1.2 ± 0.1 mg/dl), to a similar degree.
However, the sCr level at the end of follow-up did not
differ by the predominant quality factor: cellular,
3.2 ± 0.9 mg/dl; ﬁbrocellular, 2.5 ± 0.9 mg/dl; and
ﬁbrous, 2.7 ± 0.7 mg/dl (Fig. 8c). No signiﬁcant
differencewasevidentintheotherclinicalparameters,
includingthesCrlevelatbiopsyandproteinuriaatﬁnal
evaluation.
Dominant location/quality factors of segmental
lesions correlation with histological parameters
Globally sclerotic glomeruli represented a signiﬁcantly
lower percentage of total glomeruli in the TIP location
(4.2 ± 1.1%) compared with the NOS (22.6 ± 3.0%)
and PH locations (19.0 ± 3.1%), and were lower in the
cellular subtype (8.1 ± 2.7%) than in the ﬁbrocellular
(19.6 ± 3.4%) and ﬁbrous subtypes (22.5 ± 3.2%;
Fig. 9a). In contrast, the percentage of segmentally
sclerotic glomeruli did not differ signiﬁcantly among
the location categories: TIP, 18.4 ± 2.3%; NOS,
20.3 ± 2.0%; and PH, 16.3 ± 1.9%. However, the
percentage of segmentally sclerotic glomeruli was
higher in the ﬁbrocellular subtype (25.7 ± 2.6%) than
in the cellular (17.2 ± 2.4%) and ﬁbrous subtypes
(17.0 ± 1.6%; Fig. 9b). The IF/TA score for the TIP
category(0.91 ± 0.17)wassigniﬁcantlylowerthanthe
score for the NOS category (1.86 ± 0.13), which was
not signiﬁcantly different from the score for the PH
category (1.53 ± 0.17). Additionally, the IF/TA score
was lower for the cellular subtype (1.10 ± 0.15)
compared with the ﬁbrocellular (1.94 ± 0.22) and
ﬁbrous subtypes (1.67 ± 0.13; Fig. 9c).
Clinical relevance of the location and quality
heterogeneity in each variant
To examine the clinical relevance of the location
and quality heterogeneity, we examined the COL,
TIP, and PH variants with different location cate-
gories (Supplemental Tables 2–4) and the COL,
CEL, and TIP variants with different quality cate-
gories (Supplemental Tables 5–7). The results
revealed that the location and quality heterogeneity
of segmental lesions have some inﬂuence on the
clinical and histological manifestations in each
variant of FSGS, but further study with a greater
number of patients is required to show distinct
statistical differences.
Discussion
The present study indicated that location heteroge-
neity of glomerular segmental lesions was observed
in the COL and TIP variants, and indistinctly in the
PH variant. The CEL and NOS variants showed a
homogenous location, because of their diagnostic
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Fig. 8 Correlation between clinical parameters and dominant
location/quality factors of segmental lesions. a Interval between
onset and biopsy (months). b Urinary protein excretion at biopsy
(g/day).cSerumcreatinine(sCr)levelatﬁnalobservation(mg/dl).
Both the location and quality of lesions were signiﬁcantly
correlated with disease duration and proteinuria at biopsy. The
outcome, as reﬂected by the sCr at the end of follow-up, was
signiﬁcantlycorrelatedwithlocation,butnotwithqualityoflesions
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123criteria. The clinical relevance of location heteroge-
neity was partly shown in the COL variant: a shorter
duration to biopsy in the COL variants affecting the
TIP area and a higher incidence of ESRD in the COL
variants affecting the NOS area. The location factor
for the segmental lesion may be important in
assessing clinical and histological ﬁndings of the
COL variants. The segmental COL lesion localized in
the TIP or PH area may indicate less serious clinical
manifestations than the typical COL variant, as
reported previously [18–23]. In contrast, the clinical
relevance of location heterogeneity was obscure in
the TIP and PH variant, meaning that the detection of
a single segmental lesion consistent with the TIP and
PH variant is generally accepted as sufﬁcient for
determining variant classiﬁcation.
Quality heterogeneity in terms of activity and
chronicity of glomerular segmental lesions was also
noticed in the COL, TIP, and CEL variants. The
activity and chronicity of glomerular lesions are good
indicators of the severity of various glomerular
diseases [12–17]. Although histological activity and
chronicity are controversial in FSGS, it is generally
accepted that hypercellular lesions are frequently
observed in patients with severe clinical manifesta-
tions, such as the COL or CEL variants of the
Columbia classiﬁcation. The present study also
indicated that the cellular characteristics of segmental
lesions were associated with a shorter delay to biopsy
and severe proteinuria, and that the quality heteroge-
neity of segmental lesions reﬂected the different
clinical and histological manifestations in the patients
with COL and CEL variants.
Determining the dominant location and quality of
glomerular segmental lesions may be useful for
estimating clinical severity and for the histological
classiﬁcation of FSGS. The dominant location of
lesions was signiﬁcantly associated with several
clinical and histological features, as originally sug-
gested by D’Agati et al. [3]. Severe clinical manifes-
tations and unfavorable outcomes were associated
with the NOS location of segmental lesions, and a
favorable outcome was associated with the TIP and
PH locations, consistent with previous studies [5, 7,
17, 22]. The TIP location correlated well with severe
proteinuria, shorter delay to biopsy, and favorable
prognosis. The PH location was associated with the
longest duration to biopsy, a lower level of protein-
uria, and, similar to the TIP location, a favorable
outcome. Similarly, the dominant quality factor
(cellular, ﬁbrocellular or ﬁbrous) of lesions was
signiﬁcantly associated with the level of proteinuria
at biopsy and the extent of glomerular sclerosis. The
cellular subtype is associated with acute and severe
clinical manifestation, and the ﬁbrous subtype repre-
sents chronic and milder clinical presentation. Thus,
the dominant quality as well as the dominant location
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Fig. 9 Correlation between histological parameters and dom-
inant location/quality factors of segmental lesions. a Globally
sclerotic glomeruli as a percentage of the total number of
glomeruli (%GS). b Segmentally sclerotic glomeruli as a
percentage of the total number of glomeruli (%SS). c Score of
interstitial ﬁbrosis and tubular atrophy (IF/TA score). Both the
location and quality of lesions were signiﬁcantly correlated
with %GS and the IF/TA score. Quality was correlated only
weakly and location not at all with %SS, meaning that the
percentage of segmentally sclerotic glomeruli was similar
across location categories and quality subtypes
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123of glomerular segmental lesions is a good indicator of
clinical manifestations.
The distinction between the COL and CEL
variants requires further investigation due to their
overlapping histological ﬁndings and the apparent
histological heterogeneity of glomerular segmental
lesions. Endocapillary hypercellularity, a diagnostic
criterion of the CEL variant, can also be encountered
in COL variant cases. Overlapping histological
ﬁndings in the COL and CEL variants sometimes
cause difﬁculty in identifying the variant [1]. This
situation may be associated with the result that no
signiﬁcant difference in the clinical and histological
ﬁndings was seen between the COL and CEL
variants. Further studies are needed to identify
distinct differences between the COL and CEL
variants as applied to cases of histologically overlap-
ping COL and CEL ﬁndings. Furthermore, it remains
to be determined which histological ﬁndings, for
example, epithelial hyperplasia or endocapillary
proliferation, are, in fact, associated with disease
activity and progression in FSGS.
In conclusion, histological heterogeneity of glo-
merular segmental lesions exists in all variants of the
Columbia classiﬁcation, except NOS, and reﬂects the
clinical diversity within each variant of FSGS.
Determining the dominant location and quality sub-
type of glomerular segmental lesions may be useful
for classifying variants and estimating clinical sever-
ity and outcome in patients with FSGS. Although the
generally conserved ﬁdelity of location and domi-
nance of histological features in the TIP, PH, and
NOS variants support the utility of the Columbia
classiﬁcation, the COL and CEL variants warrant
further investigation due to their overlapping histo-
logical ﬁndings and apparent histological heteroge-
neity of glomerular segmental lesions.
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